Search

Project Extension for Community Health Outcomes (ECHO) aims to connect community providers to academic specialists, deliver longitudinal clinical mentorship and case consultations, plus encourage dissemination of knowledge and resources. The impact on outcomes for persons with HIV (PWH) is uncertain.PWH in Washington and Oregon outside of the Seattle and Portland metro areas, January 2011 to March 2018.Using viral load (VL) surveillance data, we assessed difference in the percentage of PWH who were virally suppressed among PWH whose providers participated versus did not participate in Project ECHO. Analyses included multiple mixed-effects regression models, adjusting for time and for patient, provider, and clinic characteristics.Based on 65,623 VL results, Project ECHO participation was associated with an increase in the percentage of patients with VL suppression (13.7 percentage points greater; P0.0001), although the effect varied by estimated provider PWH patient volume. The difference was 14.7 percentage points ( P0.0001) among patients of providers who order20 VL's/quarter and 2.3 and -0.6 percentage points among patients of providers who order 20-40 or40 VL's/quarter, respectively ( P0.5). The magnitude of difference in VL suppression was associated with the number of sessions attended. Among patients of lower-volume providers who did not participate, VL suppression was 6.2 percentage points higher if providers worked in a clinic where another provider did participate ( P0.0001).Project ECHO is associated with improvement in VL suppression for PWH whose providers participate or work in the same clinic system as a provider who participates, primarily because of benefits for patients of lower-volume providers.

People living with HIV (PLWH) are at greater risk for severe COVID-19 and are a priority population for COVID-19 vaccination. As of June 15, 2021, 61.6% of PLWH in Oregon received ≥ 1 COVID-19 vaccine dose. Younger PLWH, Hispanic/Latinx PLWH and PLWH who inject drugs or reside in rural and frontier areas had low vaccine uptake while PLWH who were engaged in care, enrolled in the AIDS Drug Assistance Program, and vaccinated against influenza had high vaccine uptake. Greater advocacy, education, and care navigation are required to increase COVID-19 vaccine access and uptake among PLWH. Supplementary Information The online version contains supplementary material available at 10.1007/s10461-021-03570-9.

Over 8100 people living with HIV (PLWH) in Oregon are at risk of acquiring COVID-19, and communities of color are disproportionately impacted by both COVID-19 and HIV. This study identifies factors associated with a positive COVID-19 test among PLWH in Oregon, with the goal of promoting health equity. We probabilistically linked COVID-19 laboratory results with laboratory-confirmed HIV cases. Crude and adjusted risk ratios of having a COVID-19 diagnosis were calculated for each covariate. Almost 6% of the 2390 PLWH tested for COVID-19 had a positive COVID-19 result. PLWH with positive results tended to identify as American Indian/Alaska Native or Hispanic/Latinx. Younger (age